Detalhe da pesquisa
1.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Blood
; 142(13): 1131-1142, 2023 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363833
2.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Haematologica
; 105(12): 2805-2812, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256379
3.
Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.
Br J Haematol
; 187(3): 347-355, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31290569
4.
Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma.
Blood
; 128(19): 2297-2306, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27647864
5.
Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population.
Haematologica
; 108(1): 240-244, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073515
6.
Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands.
Anticancer Drugs
; 29(8): 791-801, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846248
7.
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.
Blood Adv
; 8(5): 1094-1104, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191686
8.
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
J Clin Oncol
; 42(16): 1903-1913, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359378
9.
Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.
Br J Haematol
; 180(3): 459-462, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27714765
10.
Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients.
Haematologica
; 103(8): e368-e371, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545338
11.
The incidence of vertebral compression fractures and spinal instability in newly diagnosed multiple myeloma patients.
J Orthop
; 38: 62-67, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974337
12.
Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment-a prospective cohort study.
J Thromb Haemost
; 21(4): 1020-1031, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696209
13.
Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists' experiences and perspectives.
Clin Nutr ESPEN
; 57: 399-409, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37739686
14.
Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg.
Ann Hematol
; 91(1): 103-7, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21484303
15.
Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
Leuk Lymphoma
; 63(5): 1070-1079, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34961399
16.
Nutrition-related problems, nutritional support practices and barriers to adherence to nutritional guidelines during intensive treatment for acute myeloid leukemia: Patients' and hematology nurses' perspectives and experiences.
Clin Nutr ESPEN
; 48: 446-455, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35331527
17.
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
Lancet Haematol
; 9(3): e190-e199, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240075
18.
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.
Haematologica
; 100(3): e90-2, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425692
19.
Identifying predictive factors for vertebral collapse fractures in multiple myeloma patients.
Spine J
; 20(11): 1832-1839, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673729
20.
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study.
Exp Hematol
; 89: 55-60.e6, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781097